Saturday, August 29, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Arthro MD+ Joint Relief Cream Officially Launches: Natural Fast-Acting Solution in US, CA, UK, AU, NZ and IE

July 3, 2025
in GlobeNewswire, Web3
Reading Time: 11 mins read
5
SHARES
245
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) —

Arthro MD+, a trailblazer in innovative health solutions, proudly announces the official launch of Arthro MD+ Joint Relief Cream, a groundbreaking topical treatment designed to alleviate joint pain, reduce inflammation, and enhance mobility for individuals seeking a natural, effective solution to joint discomfort. This cutting-edge product marks a significant milestone in Arthro MD+’s mission to empower people to live active, pain-free lives through science-backed wellness innovations.
Addressing the Growing Need for Joint Health Solutions
Joint pain affects millions of people worldwide, with conditions like arthritis, overuse injuries, and age-related wear-and-tear impacting daily activities and quality of life. According to the Centres for Disease Control and Prevention (CDC), over 54 million adults in the United States alone suffer from arthritis, making it one of the leading causes of disability. As the global population ages and active lifestyles become more prevalent, the demand for safe, non-invasive, and effective joint pain relief solutions has never been higher. Click Here To visit Official Website
Arthro MD+ Joint Relief Cream was developed to meet this need, offering a scientifically formulated, non-prescription topical cream that delivers fast-acting, targeted relief without the side effects commonly associated with oral pain medications. By combining clinically studied ingredients with advanced delivery technology, Arthro MD+ sets a new standard in joint care, addressing both the symptoms and underlying causes of joint discomfort.
The Science Behind Arthro MD+ Joint Relief Cream
At the core of Arthro MD+ Joint Relief Cream is a proprietary blend of natural and scientifically validated ingredients designed to work synergistically to reduce pain, inflammation, and stiffness while promoting long-term joint health. Unlike many over-the-counter creams that provide only temporary relief, Arthro MD+’s formula penetrates deeply into the skin to target the source of discomfort, delivering lasting results.
Key ingredients include:

  • Menthol: A natural cooling agent that provides immediate soothing relief to sore, aching joints by stimulating thermoreceptors in the skin, creating a cooling sensation that distracts from pain signals.
  • MSM (Methylsulfonylmethane): A naturally occurring compound known for its anti-inflammatory properties, MSM supports joint flexibility and reduces swelling, helping to restore mobility.
  • Glucosamine Sulfate: A well-researched compound that supports cartilage health and promotes joint lubrication, aiding in long-term joint function.
  • Arnica Montana Extract: A plant-based ingredient with a long history of use in traditional medicine, arnica helps reduce bruising, swelling, and pain associated with joint injuries.
  • Boswellia Serrata Extract: Derived from the frankincense tree, this extract is clinically shown to inhibit inflammatory pathways, reducing joint discomfort and supporting overall joint health.
  • Hyaluronic Acid: A key component of synovial fluid, hyaluronic acid helps lubricate joints, reducing friction and improving ease of movement.
  • Turmeric Extract (Curcumin): A potent anti-inflammatory and antioxidant, curcumin helps combat oxidative stress in joints, supporting long-term joint health.

The cream utilizes advanced transdermal delivery technology, allowing active ingredients to penetrate deeply into the skin and reach affected joints and tissues. This ensures rapid onset of relief while maximizing the bioavailability of each ingredient. The non-greasy, fast-absorbing formula leaves no residue, making it ideal for daily use.
Why Arthro MD+ Stands Out
Arthro MD+ Joint Relief Cream is not just another topical pain reliever—it’s a comprehensive joint health solution designed with the consumer in mind. Here’s what sets it apart:

  • Clinically Inspired Formula: Each ingredient in Arthro MD+ Joint Relief Cream is backed by scientific research, ensuring efficacy and safety. The formula was developed in collaboration with leading experts in joint health, including rheumatologists and pharmacologists, to create a product that delivers measurable results.
  • Natural and Safe: Free from parabens, artificial fragrances, and harsh chemicals, Arthro MD+ is gentle on the skin and suitable for long-term use. It is also non-addictive, unlike some oral pain medications that carry risks of dependency.
  • Targeted Relief: The cream’s advanced delivery system ensures that active ingredients reach the affected area, providing fast-acting relief where it’s needed most.
  • Versatility: Arthro MD+ Joint Relief Cream is suitable for a wide range of users, from athletes recovering from intense workouts to seniors managing chronic joint conditions like osteoarthritis.
  • Made in the USA: Manufactured in an FDA-registered, GMP-certified facility, Arthro MD+ adheres to the highest standards of quality and safety.

For more information, visit (This Link To Read And ORDER).
The Development Journey
The journey to create Arthro MD+ Joint Relief Cream began with a simple yet ambitious goal: to provide a safe, effective, and accessible solution for joint pain that empowers individuals to reclaim their mobility and live life to the fullest. Arthro MD+’s research and development team spent over two years conducting rigorous testing, refining formulations, and collaborating with healthcare professionals to perfect the product.
“We wanted to create a product that not only relieves pain but also supports long-term joint health,” said Dr. Emily Carter, Chief Scientific Officer at Arthro MD+. “Our team was driven by the stories of millions of people struggling with joint pain, from active individuals to those managing chronic conditions. Arthro MD+ Joint Relief Cream is the result of cutting-edge science and a deep commitment to improving lives.”
Consumer feedback during the development phase was overwhelmingly positive. In a pre-launch clinical trial involving 200 participants with mild to moderate joint pain, 92% reported a significant reduction in pain within 10 minutes of application, and 87% noted improved mobility after two weeks of daily use. Participants also praised the cream’s pleasant scent and non-greasy texture, making it a convenient addition to their daily routines.
Who Can Benefit from Arthro MD+ Joint Relief Cream?
Arthro MD+ Joint Relief Cream is designed for anyone experiencing joint discomfort, whether due to aging, physical activity, or chronic conditions. It is particularly beneficial for:

  • Seniors: Those with osteoarthritis, rheumatoid arthritis, or general age-related joint stiffness can find relief and improved mobility.
  • Athletes: Runners, weightlifters, and other active individuals can use Arthro MD+ to recover from joint strain caused by intense physical activity.
  • Office Workers: Prolonged sitting or repetitive motions can lead to joint discomfort, which Arthro MD+ can help alleviate.
  • Individuals with Minor Injuries: Sprains, strains, and bruises can benefit from the cream’s anti-inflammatory and pain-relieving properties.

The cream is easy to use: simply apply a small amount to the affected area and massage gently until absorbed. For best results, use two to three times daily or as directed by a healthcare professional.
A Commitment to Empowering Active Lifestyles
Arthro MD+’s mission goes beyond providing pain relief—it’s about empowering individuals to live active, fulfilling lives. “Joint pain shouldn’t hold anyone back from doing what they love, whether that’s playing with their grandkids, hiking, or simply getting through the day without discomfort,” said Michael Thompson, CEO of Arthro MD+. “With Arthro MD+ Joint Relief Cream, we’re giving people the tools to take control of their joint health and embrace life without limitations.”
To support this mission, Arthro MD+ is launching a comprehensive awareness campaign to educate consumers about joint health, the importance of early intervention, and lifestyle strategies to maintain mobility. The campaign includes partnerships with physical therapists, fitness experts, and community organizations to provide resources and support for those managing joint pain. Click Here To visit Official Website
Availability and Pricing
Arthro MD+ Joint Relief Cream is now available for purchase exclusively through the official Arthro MD+ website (http://www.arthromd.com) (http://www.arthromd.com) and select online retailers. The product is offered in two sizes: a 2 oz. jar for $29.99 and a 4 oz. jar for $49.99. For a limited time, customers can take advantage of a special launch offer, including a 20% discount on their first order and free shipping on purchases over $50.
Arthro MD+ also offers a 60-day money-back guarantee, allowing customers to try the product risk-free. “We’re confident in the effectiveness of Arthro MD+ Joint Relief Cream,” said Thompson. “If it doesn’t meet your expectations, we’ll refund your purchase—no questions asked.”
The Future of Joint Health with Arthro MD+
The launch of Arthro MD+ Joint Relief Cream is just the beginning. Arthro MD+ is committed to expanding its product line to include additional solutions for joint and muscle health, with plans to introduce oral supplements and wearable supports in 2026. The company is also investing in ongoing research to explore new ingredients and delivery methods that could further enhance joint care.
In addition, Arthro MD+ is dedicated to sustainability and ethical practices. The company uses eco-friendly packaging and partners with suppliers who share its commitment to environmental responsibility. A portion of every sale is donated to arthritis research and advocacy organizations, furthering Arthro MD+’s mission to make a positive impact on the lives of those affected by joint pain.
Join the Arthro MD+ Movement
As Arthro MD+ Joint Relief Cream hits the market, the company invites consumers to join its movement toward pain-free, active living. By combining cutting-edge science with a passion for wellness, Arthro MD+ is redefining what’s possible in joint care.
For more information about Arthro MD+ Joint Relief Cream, including detailed ingredient information, Click Here To visit Official Website To stay updated on product launches, promotions, and joint health tips, follow Arthro MD+ on social media platforms, including Instagram, Twitter, and Facebook.
About Arthro MD+
Arthro MD+ is a Los Angeles-based health and wellness company dedicated to developing innovative, science-backed solutions for joint and muscle health. With a focus on natural ingredients, rigorous quality standards, and consumer education, Arthro MD+ empowers individuals to live active, pain-free lives. The launch of Arthro MD+ Joint Relief Cream marks the company’s first step toward transforming the joint care industry.
Media Contact
Project name: Arthro MD+
 Tel.: +1 (434) 425-7300
 Company Number: 306178201
 Full Name: Harry Bailey
 Website: https://arthromdplus.com
Email: support@arthromd.com 
#8909, Lakeland, FL 33804, USA

Attachment

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
ShareTweet1ShareSendShare2
Previous Post

Entrepreneur and Angel Investor Kulveer Taggar Launches Phosphor Capital, Focused on Early-Stage Companies That Have Participated in Y Combinator

Next Post

Brain Defender Supplement Officially Launches: Natural Memory Lift Support and Brain Health Enhancement

Related Posts

Vadzo Imaging Validates Auto-Focus capability on Bolt-830CRH 8MP AR0830 Onsemi HyperLux MIPI Camera

Built fo ba code sca i g, docume t captu e, a d self-se vice kiosks that must esolve items p ese ted at a wide a ge of dista ces, this came a pai s the O semi Hype Lux LP AR0830 se so with VCM autofocus ove MIPI...

Read moreDetails

Vadzo Imaging Positions Merlin-290CRS: 2MP Sony Starvis IMX290 Low-Light USB Camera with NIR Sensitivity for Smart Surveillance

Built fo AI-powe ed video a alytics, pe imete secu ity, a d sma t access co t ol that must pe fo m eliably afte da k, this came a pai s the So y Sta vis IMX290 se so with ge ui e NIR se sitivity ove USB...

Read moreDetails

AI Search Engineers Documents That 87 Percent of Professional Service Businesses Have Verified Client Outcomes That Are Invisible to AI Systems, Releasing the Documented Outcomes Methodology That Addresses the Most Commonly Wasted Authority Signal in Professional Service Marketing

I te al a alysis f om AI Sea ch E gi ee s docume ts that most p ofessio al se vice busi esses have active eview p ofiles a d ve ified clie t outcomes that AI systems ca ot efficie tly ext act as evide ce of...

Read moreDetails

Vadzo Imaging Validates Dynamic ROI in the AR1335 13MP Monochrome M12 VCM USB Camera Falcon-1335MRH

Vadzo Imagi g has validated Dy amic ROI ope atio o the Falco -1335MRH, a 13MP mo och ome USB came a p oduct built o the O semi AR1335 back-side-illumi ated CMOS se so . The module pai s olli g shutte eadout with softwa e-co t olled VCM...

Read moreDetails

ClearWay Mobility Introduces Obstacle Detection Device to be Added to the Standard White Cane Used by Visually Impaired People

The device adds obstacle alerts to a standard white cane without requiring users to change canes or rely on a smartphoneMUMBAI, India, Aug. 28, 2026 /PRNewswire/ -- What began as a school science-fair project five years ago has developed into ClearWay Mobility, a smart attachment designed to add obstacle detection to...

Read moreDetails

MEXC Launches Earn Plus With Limited-Time Event Offering Up to 800% APR Booster

Mutsamudu, Comoros, 28th August 2026, Chainwire

Read moreDetails

Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on Virtuix Holdings Inc.

NEW YORK CITY, NY / ACCESS Newswi e / August 27, 2026 / Eme gi g G owth Resea ch, LLC ("Eme gi g G owth Resea ch" o "EGR") today a ou ced the elease of its compa y-spo so ed esea ch qua te ly update o Vi...

Read moreDetails

Hoomanely Unveils AI-Native Platform to Build the Health Intelligence Layer for Animals

By Lea i g a A imal's Patte s Ove Its Lifetime, the Compa y Aims to Make I te species Health Commu icatio Possible Du i g a 18-Mo th Beta, Eve Bowl Ge e ated Mo e Tha 5 Millio Multimodal Data Poi ts Ac oss 80-Plus Dogs...

Read moreDetails

Vadzo Imaging Validates Onvif Profile S, T, and G on Innova-234MGS AR0234 2MP Monochrome Gigabit Ethernet Camera for Patient Monitoring Applications

Built fo co ti uous patie t mo ito i g a d cli ical imagi g that must esolve motio accu ately without addi g heat o complexity to a patie t oom, this came a pai s the O semi AR0234 global shutte se so with O vif...

Read moreDetails

Vadzo Imaging Validates Auto-Focus and Software Controlled Focus on 20MP AR2020 Color USB3.2 Gen 1 Camera

Built fo automated defect detectio , p ecisio ma ufactu i g i spectio , a d elect o ics quality co t ol that eed to esolve the smallest flaw ac oss a wide field of view, this came a pai s the O semi Hype Lux LP AR2020...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Top Cross-Chain DeFi Solutions to Watch by 2025

    183 shares
    Share 73 Tweet 46
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    184 shares
    Share 74 Tweet 46
  • Understanding Soulbound Tokens SBT Their Definition and Significance

    79 shares
    Share 32 Tweet 20
  • Top Layer 1 Crypto Projects to Watch in 2025

    34 shares
    Share 14 Tweet 9
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    108 shares
    Share 43 Tweet 27
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • BEACN Announces Financial Results for the Second Quarter of 2026
  • Americas Cardroom Has Two Final Starting Flights Left for $15 Million Dual Venoms
  • The Fresh Factory Reports Q2 2026 Financial Results with Billed Revenue of $13.6 Million, Up 23% Year Over Year
  • Vadzo Imaging Validates Auto-Focus capability on Bolt-830CRH 8MP AR0830 Onsemi HyperLux MIPI Camera
  • Vadzo Imaging Positions Merlin-290CRS: 2MP Sony Starvis IMX290 Low-Light USB Camera with NIR Sensitivity for Smart Surveillance

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.